← Eichor
Condition: Epileptic Encephalopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Epileptic Encephalopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
Phase N/A · 2 location(s) · Number 2 Children's Hospital, Ho Chi Minh City · NCT06278428A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Phase 3 · 58 location(s) · Stoke Therapeutics, Inc · NCT06872125Genetics of Epilepsy and Related Disorders
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT01858285Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06967727Study of Patients with Electrical Status Epilepticus in Sleep
Phase N/A · 1 location(s) · East Suffolk and North Essex NHS Foundation Trust · NCT06792396Study of Transcranial Direct Current Stimulation to Treat Epilepsy
NA · 1 location(s) · Mayo Clinic · NCT05673915SLC6A1-NDD Prospective Longitudinal Natural History Study
Phase N/A · 3 location(s) · UCB Biopharma SRL · NCT07531511Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Phase N/A · 2 location(s) · Simons Searchlight · NCT01238250Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy.
NA · 2 location(s) · University Hospital, Strasbourg, France · NCT03865771A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Phase 3 · 10 location(s) · Praxis Precision Medicines · NCT07019922North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Phase N/A · 17 location(s) · Columbia University · NCT01694940Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies
NA · 4 location(s) · Azienda Ospedaliero-Universitaria di Modena · NCT06855901Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Phase 3 · 11 location(s) · Praxis Precision Medicines · NCT07010471A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06585605A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Phase 1/Phase 2 · 3 location(s) · Praxis Precision Medicines · NCT05737784Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data
Phase N/A · 23 location(s) · Imagine Institute · NCT06380192Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT07413211A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndro
Phase 1/Phase 2 · 14 location(s) · Encoded Therapeutics · NCT05419492A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · 102 location(s) · Longboard Pharmaceuticals · NCT06660394STXBP1 and SYNGAP1 Related Disorders Natural History Study
Phase N/A · 5 location(s) · Children's Hospital of Philadelphia · NCT06555965Neuroimmunology Registry and Biobank
Phase N/A · 2 location(s) · Charite University, Berlin, Germany · NCT06958341BMB-101 in Absence Epilepsy and DEE
Phase 2 · 5 location(s) · Bright Minds Biosciences Pty Ltd · NCT06401538Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Phase N/A · 15 location(s) · Assistance Publique Hopitaux De Marseille · NCT04802135Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04421846Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
Phase 1 · 1 location(s) · Heather Olson · NCT06700811Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders.
Phase 1/Phase 2 · 1 location(s) · Pirogov Russian National Research Medical University · NCT07363603Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder
Phase 1/Phase 2 · 1 location(s) · TESS Research Foundation · NCT07102524A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders
Phase N/A · 1 location(s) · European STXBP1 Consortium · NCT06625112
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.